Arthritis Therapy Gorham ME

Local resource for arthritis therapy in Gorham. Includes detailed information on local businesses that provide access to arthritis pain relief, arthritis medication, arthritis natural treatments, rheumatoid arthritis treatments, physical therapy, and occupational therapy, as well as advice and content on arthritis surgery.

Brian Joseph Keroack, MD
(207) 774-5761
51 Sewall St
Portland, ME
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1985

Data Provided By:
Dr.Sarah Muscat
(207) 774-5761
51 Sewall Street #1
Portland, ME
Gender
F
Education
Medical School: A Einstein Coll Of Med Of Yeshiva Univ
Year of Graduation: 1984
Speciality
Rheumatologist
General Information
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 1, reviews.

Data Provided By:
Marc Lawrence Miller, MD
(207) 774-5761
51 Sewall St
Portland, ME
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Univ Of Pa Sch Of Med, Philadelphia Pa 19104
Graduation Year: 1977

Data Provided By:
Charles D Radis, DO
51 Sewall St
Portland, ME
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Univ Of Hlth Sci, Coll Of Osteo Med, Kansas City Mo 64124
Graduation Year: 1981

Data Provided By:
Sidney Robert Block
(207) 945-9442
275 Union St
Bangor, ME
Specialty
Rheumatology

Data Provided By:
Sarah Davy Muscat, MD
(207) 774-5761
51 Sewall St
Portland, ME
Specialties
Internal Medicine, Rheumatology
Gender
Female
Education
Medical School: A Einstein Coll Of Med Of Yeshiva Univ, Bronx Ny 10461
Graduation Year: 1984

Data Provided By:
Dr.Brian Keroack
(207) 774-5761
51 Sewall Street
Portland, ME
Gender
M
Education
Medical School: Tufts Univ Sch Of Med
Year of Graduation: 1985
Speciality
Rheumatologist
General Information
Accepting New Patients: Yes
RateMD Rating
3.2, out of 5 based on 2, reviews.

Data Provided By:
George Lester Morton, MD
(207) 774-5761
51 Sewall St
Portland, ME
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Mc Gill Univ, Fac Of Med, Montreal, Que, Canada
Graduation Year: 1968

Data Provided By:
Larry Gardner Anderson, MD
(207) 541-7531
83 Falmouth Rd
Falmouth, ME
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1967
Hospital
Hospital: Maine Med Ctr, Portland, Me

Data Provided By:
Sidney Robert Block, MD
(207) 945-9442
275 Union St
Bangor, ME
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1967

Data Provided By:
Data Provided By:

New, Targeted Therapies for Arthritis

There are many different types of rheumatological diseases. A rheumatological disease is an inflammatory arthritis that affects the entire body as a whole. Rheumatoid arthritis (RA) is the most common rheumatologic disease. Certain types of rheumatoid arthritis seem to target specific joints.

When a rheumatological disease affects the spine, the resulting conditon is called a spondyloarthropathy. The term is made up of Greek words: Spondylo means vertebra, arthro means joint and pathos means disease. When other more peripheral joints are affected (such as in the arms and legs), the rheumatologic arthritis is referred to as an spondyloarthritide.

In this article, Dr. Philip J. Mease from the Division of Rheumatology, University School of Medicine in Seattle, Washington gives us an update on two of the more common spondyloarthropathies: psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Psoriatric arthritis affects the peripheral joints. Ankylosing spondylitis affects the spine.

New findings in the field have brought these conditions and their treatment to our attention. The first major breakthrough in understanding and treating these diseases is in the area of pathophysiology. Pathophysiology tells us what went wrong at the cellular level to cause these problems.

Researchers are identifying specific differences between rheumatoid arthritis and spondyloarthropathies. Their work in the field of osteoimmunology is helping determine what's going on between the bone cells (osteo) and the immune system. This knowledge has led to more refined development of specific drug treatments for these two types of arthritis. That's good news for anyone suffering from any kind of rheumatologic disease.

For example, MRIs of patients with spondyloarthropathies show bone edema before any actual bone damage occurs in the joints. At the same time, they have found nests of lymphocytes (white blood cells), bone cells, and blood in the bone marrow (inside bones) of patients with ankylosing spondylitis. Though the exact meaining of these findings are unknown, they point in a direction to help drug manufacturers develop medications that could stop this process.

Measuring the effect of therapy on disease activity is one way to assess new treatments. Studies look at before and after outcomes of therapy on affected joints, skin, pain, function, fatigue, and quality of life. The therapeutic effects of treatment on disease activity can be difficult to measure -- especially when those changes occur at the cellular level. MRIs and X-rays may be helpful.

Patient-reported outcomes using various surveys can help track patient perceived changes, too. Some of these tools include the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Function Index (BASFI), and the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire.

Standard treatment of mild spondyloarthropathies start...

Click here to read the rest of this article from eOrthopod.com